MetaCap

Centene Financial Statements

NYSE: CNCHealth CareMedical SpecialitiesUSD

65.36+0.82 (+1.27%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Centene revenue and earnings

In fiscal 2025, Centene generated $194.78 billion in revenue, up 19.4% from fiscal 2024, its 17th consecutive year of revenue growth. Centene reported a net loss of $6.67 billion, compared with net income of $3.31 billion a year earlier. Gross margin was 7.3% (down from 10.5%) and operating margin -3.9%.

Diluted earnings per share came in at -$13.53, down from $6.31. Over the last 5 fiscal years, CNC's revenue has grown at a 11.9% compound annual rate.

Summary generated from market data by MetaCap's automated system. Methodology

Centene income statement (annual)

Centene annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31FY 20162016-12-31
Revenue194.78B163.07B154.00B144.55B125.98B111.11B74.64B60.12B48.38B40.61B
Revenue growth (YoY)+19.44%+5.89%+6.54%+14.74%+13.38%+48.87%+24.16%+24.25%+19.15%+78.41%
Cost of Revenue2.67B2.73B3.56B7.03B4.89B3.30B2.46B2.39B1.85B1.86B
Gross Profit14.21B17.07B17.64B16.92B14.49B107.81B72.17B57.73B46.53B38.74B
Operating Expenses21.83B13.89B14.71B15.60B12.70B104.73B70.39B56.27B45.34B37.48B
Selling, General & Admin12.90B12.40B12.56B11.59B9.60B9.38B6.53B6.04B4.45B3.67B
Operating Income-7.62B3.17B2.93B1.32B1.78B3.08B1.78B1.46B1.20B1.26B
Interest Expense678.00M702.00M725.00M665.00M665.00M728.00M412.00M343.00M255.00M217.00M
Other Income (Expense)895.00M1.08B668.00M644.00M——————
Pretax Income-6.73B4.26B3.60B1.96B1.81B2.77B1.78B1.37B1.13B1.16B
Income Tax-51.00M963.00M899.00M760.00M477.00M979.00M473.00M474.00M326.00M599.00M
Net Income-6.67B3.31B2.70B1.20B1.35B1.81B1.32B900.00M828.00M562.00M
Net Income growth (YoY)-301.94%+22.32%+124.79%-10.76%-25.50%+36.87%+46.78%+8.70%+47.33%+58.31%
EPS (Basic)-13.536.334.972.092.313.173.192.312.401.76
EPS (Diluted)-13.536.314.952.072.283.123.142.262.341.71
Shares Outstanding (Basic)493.12M521.79M543.32M575.19M582.83M570.72M413.49M390.25M344.85M319.13M
Shares Outstanding (Diluted)493.12M523.74M545.70M582.04M590.52M579.13M420.41M398.51M353.40M327.95M
EBITDA-6.35B4.42B4.22B2.75B3.12B4.34B2.42B1.95B1.56B1.54B
Gross Margin7.30%10.47%11.45%11.70%11.50%97.03%96.70%96.03%96.18%95.41%
Operating Margin-3.91%1.95%1.90%91.00%142.00%2.77%2.39%2.43%2.48%3.11%
Net Margin-3.43%2.03%1.75%83.00%107.00%1.63%1.77%150.00%1.71%138.00%

This table shows 10 annual periods of Centene's income statement, from FY 2025 back to FY 2016, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow CNC's reporting calendar. What is a income statement?

More financial data